# David Lebwohl

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-lebwohl/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,486 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 44 |
| i10-index | 71 |
| Last Known Institution | Intellia Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5062128184 |
| ORCID iD | https://orcid.org/0000-0002-4578-1977 |
| Works | 90 |

## Researcher papers

- [Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia](https://scholariq.org/papers/tisagenlecleucel-in-children-and-young-adults-with-b-cell-lymphoblastic-leukemia/)
- [Everolimus for Advanced Pancreatic Neuroendocrine Tumors](https://scholariq.org/papers/everolimus-for-advanced-pancreatic-neuroendocrine-tumors/)
- [Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/everolimus-plus-octreotide-long-acting-repeatable-for-the-treatment-of-advanced/)
- [Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/everolimus-for-angiomyolipoma-associated-with-tuberous-sclerosis-complex-or/)
- [Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial](https://scholariq.org/papers/daily-oral-everolimus-activity-in-patients-with-metastatic-pancreatic/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Researcher university

- [Intellia Therapeutics (United States)](https://scholariq.org/institutions/intellia-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.